Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06785467

eDoula Feasibility and Acceptability

eDoula is an app that will give patients reading material and videos to watch based on their due date. It also provides helpful postpartum guidance. First, patients without access to the app will be recruited and surveyed on their labor and satisfaction outcomes. Then, recruitment will begin for the intervention arm of the study. Participants will be recruited to use the app and complete a survey during the postpartum period.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Pregnancy Related

Age range

18 year–50 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Oregon Health & Science University

Portland, Oregon, 97239, United States

Location status: Recruiting

Location contact

Women's Health Research Unit

CONTACT

[email protected]

503-494-3666

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Nulliparous
  • Singleton pregnancy
  • English speaking
  • Own a smart phone or other device capable of downloading and running the eDoula app
  • Delivered at 36 weeks 0 days gestation or later
  • Able to labor

Exclusion criteria

  • Planned cesarean delivery
  • Pregnancy complications including placenta accreta spectrum, vasa previa, intrauterine fetal demise, or known major fetal anomaly
  • Delivery planned at a location other than Oregon Health and Science University

Treatment and study plan

eDoula App

Other

eDoula is an app that will give patients reading material and videos to watch based on their due date. It also provides helpful postpartum device.

Primary outcomes

  1. Satisfaction with eDoula app

    Time frame: Measured in the 7 days following delivery

    Participant-reported satisfaction with the eDoula app using a 3-question Likert scale. Scores can have a value from 3 to 15, with a higher score indicating greater satisfaction.

  2. eDoula App Use

    Time frame: Recruitment (19-28 weeks gestation) to delivery

    The number of days during pregnancy that the eDoula app was used

Secondary outcomes

  1. Labor Agentry Scale-10 (LAS-10)

    Time frame: Measured in the 7 days following delivery

    Instrument measuring patient control during childbirth. Scores can have a value from 10 to 70, with a higher score indicating a better outcome.

  2. Birth Satisfaction Scale-Revised (BSS-R)

    Time frame: Measured in the 7 days following delivery

    Instrument measuring patient satisfaction with the birth experience. Scores can have a value from 0 to 40, with higher scores representing greater birth satisfaction.

  3. Edinburgh Postnatal Depression Scale (EPDS)

    Time frame: Measured in the 7 days following delivery

    Instrument measuring postnatal depression symptoms following delivery. Scores can have a falue from 0 to 30, with higher scores representing more symptoms of postnatal depression.

Study contacts

Contact information is provided by the study sponsor or research team.

Women's Health Research Unit Department of Ob/Gyn

CONTACT

[email protected]

503-494-3666

Sponsors and collaborators

Lead sponsor

Oregon Health and Science University

Other

Registry information

Official study title

eDoula: The Feasibility and Acceptability of Mobile Application in Pregnancy, Labor, and Birth Support

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jan 21, 2025
Registry last updated
Apr 22, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.